Five Alarm Bio is developing small molecules that target an unexplored mechanism of aging to reduce cellular senescence and chemical damage, thereby enhancing the healing capacity of aged cells. This approach aims to delay or prevent the onset of various age-related diseases, ultimately promoting healthier, more functional lives for older individuals.
Funding
$603.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
As organisms age, they experience a decline in cellular defenses against chemical damage and an increase in senescent cells, leading to a higher susceptibility to age-related diseases and impaired healing capacity. The accumulation of chemical damage from both external sources and internal metabolic processes disrupts cellular functions, contributing to the onset of chronic diseases and disabilities.
Solution
Five Alarm Bio is developing small molecule therapeutics that target a novel mechanism of aging to bolster cellular defenses and reduce chemical damage, thereby enhancing the regenerative capacity of aged cells. Their approach focuses on modulating a biological pathway involved in protecting cells from the harmful effects of chemical exposure and metabolic byproducts. By strengthening these defenses, the company aims to delay or prevent the onset of a broad range of age-related diseases, promoting healthier aging and improved cellular function. Preclinical studies using human skin cells have demonstrated a reduction in cell senescence and improved wound-healing capabilities.
Target Audience
The primary target audience includes individuals at risk of or affected by age-related diseases, as well as pharmaceutical companies seeking novel therapeutics for aging and chronic conditions.
Features
- Small molecule compounds designed to enhance cellular defenses against chemical damage.
- High-content imaging platform for screening and identifying potent molecules.
- Demonstrated reduction in cellular senescence in primary human skin cells.
- Improved wound-healing rates in in vitro cell culture models.
- Collaboration with research institutions to investigate applications in neurodegenerative diseases.
- Preclinical validation in _C. elegans_ demonstrating a 40% increase in healthspan.